Left Ventricular Hypertrophy in CKD Patients

Starting soon

Conditions studied: Left Ventricular Hypertrophy

In brief

The goal of this observational study is to determine the prevalence of left ventricular hypertrophy among patients with chronic kidney disease at Sohag University Hospital and assess the effect of erythropoietin therapy on left ventricular mass and geometry in anemic CKD patients. The main question it aims to answer is: Does erythropoietin therapy mitigate or even reverse LVH and improve cardiac geometry ?

Key facts

Study ID

NCT07380893

Run by

Sohag University

People needed

100

Starts

2026-01-15

Expected to finish

2026-07-15

Last updated by the study team

2026-02-02

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults (≥18 years) diagnosed with CKD stages 3-5.
• Stable clinical condition for ≥3 months.
• Anemia (Hb <10 g/dL) for cohort phase.
• Willingness to participate and provide informed consent.

You may not qualify if…

• Valvular or ischemic heart disease.
• Uncontrolled hypertension (BP >180/110 mmHg).
• Acute coronary syndrome or decompensated heart failure in the past 3 months.
• Malignancy or active infection

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.